Funding Cycle IX – Letter of Intent Submission in October 2002
The Roche Organ Transplantation Research Foundation (ROTRF) is very pleased to announce that following its ninth cycle of grant review, nine research grants have been awarded to scientists around the world. The grants allocated in this cycle total 2.1 million Swiss francs (CHF). The Board of Trustees and the Scientific Advisory Committee of the ROTRF were once again very pleased with the high quality and innovation demonstrated in the applications received.
The ROTRF received 89 letters of intent from scientists around the world. Almost half of the applications came from Europe (49%), the major countries being the UK (16%), Germany (12%), France (8%), while 41% came from the United States (35%) and Canada (6%). Australia, Brazil and Colombia accounted for the remaining 10% of the applicants.
All the letters of intent were reviewed by the Scientific Advisory Committee for scientific quality and originality, and based on these reviews the Board of Trustees invited the 21 topranked applicants to prepare full paper submissions.
After thorough review, nine projects were awarded full or partial grants of up to a maximum of CHF 300 000: four from the United States, two from Canada and one each from Australia, Germany and the United Kingdom.
The abstracts of the novel and promising research projects that received funding in this ninth cycle are presented on the following pages. The research projects focus mainly on the improvement of long-term graft survival, the prevention of chronic organ dysfunction, the induction of tolerance and the improvement of donor organ preservation.
